2796 — Pharmarise Holdings Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeMicro CapValue Trap

Annual balance sheet for Pharmarise Holdings, fiscal year end - May 31st, JPY millions except per share, conversion factor applied.

	2021 May 31st	2022 May 31st	2023 May 31st	2024 May 31st	2025 May 31st
Period Length:	—	—	—	—	—
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	4,604	3,991	4,742	7,150	4,911
Net Total Accounts Receivable
Net Total Receivables	3,085	4,265	4,017	3,553	3,781
Total Inventory
Total Other Current Assets
Total Current Assets	10,546	10,878	11,372	13,737	13,239
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6,434	6,355	6,010	6,198	7,209
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	24,724	23,746	23,421	29,486	31,924
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9,392	8,477	9,835	10,688	11,988
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	18,503	17,138	16,539	22,124	25,055
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	6,221	6,608	6,882	7,362	6,869
Total Liabilities & Shareholders' Equity	24,724	23,746	23,421	29,486	31,924
Total Common Shares Outstanding